CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Open-market sale SVP, GENERICS sold 881 shares at $60.07 ($52,922)
- 4 Open-market sale HEAD OF RARE DISEASE sold 4,000 shares at $60.45 ($241,800)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $62.20 ($24,880)
- 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 700 shares at $76.83 ($53,781)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $68.96 ($27,584)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Shares withheld for taxes PRESIDENT & CEO gave up 17,455 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & CFO gave up 6,210 shares (to pay taxes)
- 4 Planned sale SVP, CHIEF HR OFFICER sold 1,866 shares at $65.00 ($121,290)
- 8-K Event Other events
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $63.33 ($25,332)
Page 10 of 90 · 1,784 filings